Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) Asset Utilization Ratio: 2024-2025

Historic Asset Utilization Ratio for Immunocore Holdings (IMCR) over the last 2 years, with Sep 2025 value amounting to 0.35.

  • Immunocore Holdings' Asset Utilization Ratio rose 23.60% to 0.35 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.35, marking a year-over-year increase of 23.60%. This contributed to the annual value of 0.39 for FY2024, which is 13.01% down from last year.
  • According to the latest figures from Q3 2025, Immunocore Holdings' Asset Utilization Ratio is 0.35, which was up 2.95% from 0.34 recorded in Q2 2025.
  • Immunocore Holdings' Asset Utilization Ratio's 5-year high stood at 0.35 during Q3 2025, with a 5-year trough of 0.28 in Q2 2024.
  • Its 2-year average for Asset Utilization Ratio is 0.31, with a median of 0.33 in 2025.
  • Over the last 5 years, Immunocore Holdings' Asset Utilization Ratio had its largest YoY gain of 23.60% in 2025, and its largest YoY loss of 1.81% in 2025.
  • Quarterly analysis of 2 years shows Immunocore Holdings' Asset Utilization Ratio stood at 0.30 in 2024, then increased by 23.60% to 0.35 in 2025.
  • Its Asset Utilization Ratio stands at 0.35 for Q3 2025, versus 0.34 for Q2 2025 and 0.33 for Q1 2025.